IMV Receives NASDAQ Delisting Notice
DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass., May 08, 2023--(BUSINESS WIRE)--IMV Inc. (the "Company" or "IMV") (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and hematologic cancer...